Intelligence Platform

Patents

Browse 200 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7655762

Monoclonal antibodies against ANGPTL4

LEXICON PHARMACEUTICALS, INC. · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622113

Monoclonal antibodies that bind or neutralize dengue virus

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566540

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563874

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7501494

Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatme

United Biomedical, Inc. · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7459536

HGF-SF monoclonal antibody combinations

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7335356

Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotei

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7256004

Variants of humanized anti-carcinoma monoclonal antibody CC49

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7198788

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing C

The Board of Regents of the University of Texas System · Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7183389

Monoclonal antibodies and cell surface antigens for the detection and treatment of small c

Molecular Discoveries, Inc. · Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7175845

Monoclonal antibodies against ricin toxin and methods of making and using thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105643

Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the sa

The United States of America as represented by the Attorney General of the Dept. of Justice · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7094883

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6924362

Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 02 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6875433

Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotei

The United States of America as represented by the Secretary of the Army · Granted Tue Apr 05 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6818749

Variants of humanized anti carcinoma monoclonal antibody cc49

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6689362

Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal anti

Regents of the University of Minnesota · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6630144

Monoclonal antibodies to Ebola glycoprotein

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6620412

Prophylactic and therapeutic monoclonal antibodies

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6551599

Monoclonal antibodies against campylobacter jejuni and campylobacter coli outer membrane a

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6506885

Monoclonal antibodies to the drug tilmicosin and a method for detecting the same

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6475741

Neutrophil chemotactic factor cloned cDNA and monoclonal antibodies thereto

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6451309

Prophylactic and therapeutic monoclonal antibodies

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6399062

Murine monoclonal antibody protective against Plasmodium vivax malaria

United States of America as represented by the Secretary of the Air Force · Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired